Comments
kvorak wrote: Finally... somebody agrees. The reason people can't answer this question objectively is because it's the WRONG QUESTION, lol. Well said.
Cloud Expo on Google News

SYS-CON.TV

2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Click For 2008 West
Event Webcasts
Analyst Choice Updated Analysis on DENTSPLY International Inc., PAETEC Holding Corp., Antigenics Inc., Cubist Pharmaceuticals Inc., Alkermes Inc. and Biogen Idec Inc.
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).

NEW DELHI, INDIA -- (Marketwire) -- 11/23/09 -- All ten sectors ended in the red today led by technology, financial and energy sectors. Consumer staples and healthcare sectors registered the least losses. This drove us to do research on the following 6 stocks DENTSPLY International Inc. (NASDAQ: XRAY), PAETEC Holding Corp. (NASDAQ: PAET), Antigenics Inc. (NASDAQ: AGEN), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), Alkermes Inc. (NASDAQ: ALKS) and Biogen Idec Inc. (NASDAQ: BIIB). You can now access these research reports with many others by signing up at Analyst Choice.


To see if our analysts believe you should BUY, SELL or HOLD these six stocks sign up at Analyst Choice.

The following are exempts of the above reports:

--  XRAY seems to be weathering the downturn well.

--  PAETEC is well positioned with management debt, financial strength
    and...

--  In August, Antigenics raised $20 million through two separate private
    placements of common stock and...

--  Cubist's strong top and bottom line results have been achieved in an
    environment that has been tough for many branded pharmaceuticals.

--  Alkermes performed reasonable in this economic downturn. Its financial
    and operating results remain strong and...

--  During the third quarter BIIB drove a clear acceleration of TYSABRI
    patient growth that puts the drug on a blockbuster run-rate.
    

You can now access these full research reports along with many others by signing up for free at Analyst Choice or www.analystchoice.com.

About Analyst Choice:

Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. While the world economy undergoes enormous pressure and unprecedented actions are been taken to avoid the worst and boost the shrinking global economic growth, our analysts brings you a bird's eye view of how the big players in the different key sectors and industries of the NASDAQ and NYSE, are coping. Sign up now by visiting the following link. http://www.analystchoice.com/

AnalystChoice.com is an independent financial research portal and as such has not received any compensation by any of the above mentioned companies.

NASDAQ:AGEN NASDAQ:XRAY NASDAQ:PAET NASDAQ:CBST NASDAQ:ALKS NASDAQ:BIIB
About Marketwire .
Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Cloud Developer Stories
Why Attend Tech Ed 2010? Because you'll return to your office with knowledge and expertise that only four days at Tech Ed can offer. You can learn about today’s cutting-edge trends, helping make life easier for you (and everyone else) at work. But the most important benefit just ...
SYS-CON Events announced today that NetStar Systems, an IT and consulting provider supporting federal and private sectors, will exhibit at SYS-CON's 5th International Cloud Expo (www.CloudComputingExpo.com), which will take place on April 19-21, 2010, at the Jacob Javits Conventi...
CA and NetApp on Tuesday announced an extension of their multi-year solutions partnership to develop management solutions for public and private cloud environments. As a result, the companies are integrating CA'svirtualization, automation and service assurance offerings with NetA...
COLT, a European provider of business communications and managed services, today announced that the company has selected TIBCO's cloud software to provide organisations throughout Europe with the ability to deploy and manage enterprise applications across physical, virtual and cl...
Bick Group has announced the acquisition of Blue Mountain Labs (BML), a consulting and strategic advisory organization focusing on the emerging cloud computing space and the practical application of cloud computing within enterprise and government organizations. Terms of the deal...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021

SYS-CON Featured Whitepapers
ADS BY GOOGLE